How generative AI will ruin science and academic research

I often come back to Neil Postman’s 1985 classic Amusing Ourselves to Death. It’s a penetrating analysis on the cognitive effects of media technology. His focus is mainly on how the format and mode of communication influences the character of content and how that content then trains us, but to a lesser extent also how the discourse and the “atmosphere” of the information exchange affects these issues.

This is almost forty years ago, and the disruptive medium under scrutiny is television. The entire approach seems almost quaint, the 80s in relation to the current period being a comparative golden age of critical thinking, complex exposition and conscious, creative citizens.

Still, the issues Postman emphasizes were already significant way back then. You can summarize his criticism with television’s format having complex, detrimental effects on the content and character of public discourse, as well as on the cognitive abilities of human beings, especially in terms of understanding complex issues and parse arguments and evidence with many layers and branching implications.

The basic issue on Postman’s view is that written exposition and complex oral tradition alike foster and prepare the human mind for the rigors of critical thinking and rational reflection. And to the contrary, that the entertainment media and discourses as exemplified by television in particular, geared towards short-term gratification and the communication of sensational experiences, have rather the opposite effect.

His examples are really glaring, even back then:

Contradiction, in short, requires that statements and events be perceived as interrelated aspects of a continuous and coherent context. Disappear the context, or fragment it, and contradiction disappears. This point is nowhere made more clear to me than in conferences with my younger students about their writing. “Look here,” I say. “In this paragraph you have said one thing. And in that you have said the opposite. Which is it to be?” They are polite, and wish to please, but they are as baffled by the question as I am by the response. “I know,” they will say, “but that is there and this is here.” The difference between us is that I assume “there” and “here,” “now” and “then,” one paragraph and the next to be connected, to be continuous, to be part of the same coherent world of thought. That is the way of typographic discourse, and typography is the universe I’m “coming from,” as they say. But they are coming from a different universe of discourse altogether: the “Now … this” world of television. The fundamental assumption of that world is not coherence but discontinuity. And in a world of discontinuities, contradiction is useless as a test of truth or merit, because contradiction does not exist. My point is that we are by now so thoroughly adjusted to the “Now … this” world of news—a world of fragments, where events stand alone, stripped of any connection to the past, or to the future, or to other events—that all assumptions of coherence have vanished. And so, perforce, has contradiction. In the context of no context, so to speak, it simply disappears. And in its absence, what possible interest could there be in a list of what the President says now and what he said then? It is merely a rehash of old news, and there is nothing interesting or entertaining in that.

– Postman, ibid.

This is not an unfamiliar situation for most of us. I even had a similar experience this morning in an attempted discussion with someone who incredibly enough stated four (!) different, mutually incompatible things within the framework of a couple of short paragraphs, and he of course still kept insisting I was wrong. His stated position contained the following propositions:

  1. Beliefs are absurd
  2. Beliefs ought to be held only due to acceptable evidence
  3. You can hold beliefs for whatever reasons you like
  4. Beliefs are by definition anchored in emotion and not acceptable evidence

All of these statements are literally incompatible with every single other one.

It’s like a convoluted version of the Liar’s Paradox. If I agree with him, I’m necessarily wrong, and if I disagree, I’m wrong too. But in contrast to the old thought experiment, where my error lies in the direct affirmation of a statement’s opposite, here there’s literally no way to make sense of how I would be wrong if I either agree with or reject his position, since it’s internally incoherent in a complex and not only binary sense.

Keep reading

FLASHBACK: Air Force research: How to use social media to control people like drones

Facebook isn’t the only organization conducting research into how attitudes are affected by social media. The Department of Defense has invested millions of dollars over the past few years investigating social media, social networks, and how information spreads across them. While Facebook and Cornell University researchers manipulated what individuals saw in their social media streams, military-funded research—including projects funded by the Defense Advanced Research Projects Agency’s (DARPA) Social Media in Strategic Communications (SMISC) program—has looked primarily into how messages from influential members of social networks propagate.

One study, funded by the Air Force Research Laboratory (AFRL), has gone a step further. “A less investigated problem is once you’ve identified the network, how do you manipulate it toward an end,” said Warren Dixon, a Ph.D. in electrical and computer engineering and director of the University of Florida’s Nonlinear Controls and Robotics research group. Dixon was the principal investigator on an Air Force Research Laboratory-funded project, which published its findings in February in a paper entitled “Containment Control for a Social Network with State-Dependent Connectivity.”

The research demonstrates that the mathematical principles used to control groups of autonomous robots can be applied to social networks in order to control human behavior. If properly calibrated, the mathematical models developed by Dixon and his fellow researchers could be used to sway the opinion of social networks toward a desired set of behaviors—perhaps in concert with some of the social media “effects” cyber-weaponry developed by the NSA and its British counterpart, GCHQ.

Keep reading

New Mexico Senate Committee Unanimously Approves Psilocybin Therapy And Research Resolution

A New Mexico Senate committee has unanimously approved a bipartisan resolution requesting that state officials research the therapeutic potential of psilocybin and explore the creation of a regulatory framework to provide access to the psychedelic.

The Senate Health and Public Affairs Committee voted 7-0 to pass the resolution from Senate Minority Whip Craig Brandt (R) and Sen. Jeff Steinborn (D) on Saturday.

As “memorial” legislation, the bicameral proposal wouldn’t be binding. Rather, it would represent a formal request for the state Department of Health to “study the efficacy of using psilocybin mushrooms for therapeutic treatments and the establishment of a program for psilocybin mushrooms to be used for therapeutic medical treatments.”

The whereas section of the resolution cites various studies supporting the therapeutic benefits of psilocybin for conditions such as major depression and substance misuse, while pointing out that the federal Food and Drug Administration (FDA) has designated the psychedelic as a “breakthrough therapy.”

To that end, the measure states that the health department should look into “necessary statutory or regulatory framework for developing” a state-level psilocybin program.

“This can help people very potentially, and so what we’re trying to do in a bipartisan way is ask the Department of Health to recognize that we want them to get going to start looking at this,” Steinborn said during Saturday’s committee hearing.

The measure “really seeks to expand therapeutic options for New Mexicans,” he said.

Keep reading

Indiana House Panel Approves Psilocybin Research Bill That Already Passed Full Senate

An Indiana House committee has approved a Republican-led bill that would fund clinical research trials into psilocybin that has already cleared the full Senate.

After adopting one amendment, the House Public Health Committee advanced the legislation in a 12-1 vote on Tuesday.

“This is not fringe science at this point, so my original intent was to elevate this potential,” Sen. Ed Charbonneau (R), the bill’s sponsor, told panel members ahead of the vote. “It creates hope for people that currently are in hopeless situations.”

“I think it’s important that we get clear right up front that this bill does not make anything legal that’s illegals today,” he said, highlighting the research-focused nature of the legislation.

Rep. Brad Barrett (R), who chairs the committee, said he was initially “incredibly skeptical” of psilocybin’s therapeutic potential but was moved by testimony he heard during an interim study session on the issue that lawmakers convened last year and “left there with the same kind of feeling” that Charbonneau expressed about the psychedelic’s ability to help people.

Last week, the Senate passed the psychedelics measure in a 47-1 vote. That followed the proposal being passed unanimously by the Senate Appropriations Committee and the Health and Provider Services Committee.

Keep reading

PERCEPTION OF TIME CAN DRAMATICALLY ALTER THIS CRUCIAL BIOLOGICAL PROCESS, NEW STUDY REVEALS

New research from Harvard University shows that a person’s perception of time can directly affect how fast wounds heal.

Previous studies have hinted at a link between the mind and body, particularly in relation to stress and lifestyle. However, this study is the first to show a direct connection between the perception of time and the seemingly autonomous process of healing, opening up the possibility of incorporating time perception into the treatment of injury.

HEALING AND HUMAN PERCEPTION OF TIME

Published in the journal Nature Scientific Reports, the study conducted by Harvard psychologists Peter Aungle and Ellen Langer aimed to determine if the rate of healing was independent of the psychology of the patient or if their perceptions could accelerate or decelerate the healing process.

“Based on the theory of mind–body unity—which posits simultaneous and bidirectional influences of mind on body and body on mind—we hypothesized that wounds would heal faster or slower when perceived time was manipulated to be experienced as longer or shorter respectively,” the researches behind the finding write.

As noted, previous work had found connections between recovery from injury and stress levels, with higher levels of stress potentially interrupting a healthy recovery from injury, but those connections were thought to be primarily physiological in nature.

The researchers also note that previous work studying psychological influences on chronic pain, emotion, and physiological health, and even placebo effects, particularly those involving administration of inert medications, “have led to meaningful improvements in treatments for a broad range of illnesses and injuries.”

Still, this latest study is the first to look at the mindset of the individual, specifically their perception of the passage of time, in relation to recovery rates.

“We hypothesized that experimentally induced wounds would heal faster when more perceived time had passed and heal slower when less perceived time had passed,” the researchers explain, “despite no differences in actual elapsed time.”

Keep reading

DEA Calls For Even More THC, Psilocybin And DMT To Be Produced For Research In 2024

The Drug Enforcement Administration (DEA) is now calling for the production of even more THC, psilocybin and DMT for research purposes than it initially proposed for 2024—raising its quotas for those drugs while maintaining already high production goals for marijuana and other psychedelics.

In a notice set to be published in the Federal Register on Wednesday, DEA said it received comments from registered manufacturers requesting increases to previously proposed 2024 quotas for the Schedule I substances in order to “meet medical and scientific needs,” and it agreed to do so in the new final order.

Accordingly, the agency nearly doubled the quotas for delta-9 THC and all other tetrahydrocannabinol, increasing them to 1,523,040 grams and 1,166,130 grams, respectively.

Keep reading

DEA Renews Push To Ban Two Psychedelics After Abandoning Effort Last Year, Prompting Researchers To Fight Back Again

The Drug Enforcement Administration (DEA) is taking another shot at banning two psychedelics after abandoning its original scheduling proposal last year, teeing up another fight with researchers and advocates who say the compounds hold therapeutic potential.

In a notice published in the Federal Register on Wednesday, DEA again proposed placing 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I of the Controlled Substances Act (CSA).

The agency said that its scientific and medical basis for proposing the ban “remains the same” as it was last year, so it’s making an identical argument that the phenethylamine hallucinogens hold high abuse potential with no known medical value. What’s changed in the new notice appears to be related to the administrative process of requesting a hearing challenging the facts or laws governing the scheduling action.

When it withdrew its earlier notice, DEA mentioned that it would be “publishing a new proposed rule using an amended procedure.”

DEA doesn’t explain why the amended procedure was necessary, but it is the case that scientists rallied last year to request a hearing on its DOI and DOC scheduling proposal. The psychedelic research company Panacea Plant Sciences had also filed a motion contesting the policy change, which could’ve resulted in an administrative judge scheduling a hearing.

Unlike the previous notice, this latest filing says that the “decision whether a hearing will be needed to address such matters of fact and law in the rulemaking will be made by the Administrator.” There are suspicions that DEA is effectively complicating the process for outside parties to challenge the proposal.

In any case, Panacea Plant Sciences is again sounding the alarm. Founder and CEO David Heldreth told Marijuana Moment on Friday that the “response to our rallying cry to fight the DEA’s illogical rule making has been amazing.”

“The psychedelic community from lawyers and researchers to community activists and even individual people have really come together in opposition to the DEA prohibition mindset,” he said. “Panacea have had contact with at least 10 groups that want to be involved or support the legal fight against the DEA attempt to criminalize DOI and DOC. These compounds are intrinsically important to researchers and the scientific study of the mind and body.”

Keep reading

CONGRESS IS PUSHING REVOLUTIONARY RESEARCH ON PSYCHEDELIC TREATMENTS FOR THE MILITARY

CONGRESS IS ON track to approve legislation that would mark a significant advance in U.S. policy toward psychedelics. 

Tucked into the National Defense Authorization Act of 2024 is a provision to fund clinical trials using psychedelic substances to treat active duty members of the military.

Section 723 of the NDAA directs the secretary of defense to partner with a federal or state government agency, or an academic institution, to carry out the research. The bill would fund the treatment of members of the military with post-traumatic stress or a traumatic brain injury with a number of psychedelic substances, including MDMA, psilocybin, ibogaine, DMT, and other plant-based alternative therapies (such as ayahuasca).

Research surrounding psychedelics as a possible treatment for post-traumatic stress disorder have slowly grown, and recent studies have shown promising results, with patients benefiting from even just a few treatments including MDMA and psilocybin. Already, the Food and Drug Administration has designated both treatments as “breakthrough therapies”: a special designation given to expedite the research and development into drugs with the potential to treat serious conditions. On Tuesday, MAPS Public Benefit Corporation, which focuses on psychedelic treatments for mental health issues, submitted a new drug application to the FDA for MDMA-assisted therapy for PTSD. The company says it’s the first such submission for any psychedelic-assisted therapy.

Keep reading

Colorado Governor Says Marijuana Prohibition Created A ‘Chicken And The Egg’ Research Dilemma That’s Blocked Federal Reform

The governor of Colorado says that while marijuana reform is “not really a partisan issue” anymore, there are still “stodgy nanny state Republicans who want to control it.” Meanwhile, he says, ongoing prohibition has inhibited research into the science of cannabis that’s kept it strictly criminalized at the federal level.

Gov. Jared Polis (D) is hoping that will change sooner rather than later. He and the governors of five other states sent a letter to President Joe Biden this week, urging officials to reschedule marijuana under the Controlled Substances Act (CSA) by the end of the year.

In an interview that aired on Fox News Radio’s “The Guy Benson Show” on Thursday, Polis said he would’ve liked to see a federal policy change five or 10 years ago as states such as Colorado enacted adult-use legalization, but he theorized that prohibition itself created a “chicken and the egg” situation that has effectively stymied reform by making it harder to conduct research on the effects of cannabis, a stalemate that has been reinforced by congressional politics.

The administrative marijuana scheduling review that Biden directed last year could help break that policy logjam, he said. The U.S. Department of Health and Human Services (HHS) has already determined that cannabis should be moved from Schedule I t0 Schedule III, and now it’s up to the Drug Enforcement Administration (DEA) to make a final determination.

Keep reading

Top Federal Agency Promotes New Marijuana Research Center Amid Scientists’ Complaints About ‘Complex’ Study ‘Barriers’ Under Prohibition

A top federal health agency says it recognizes that there are ample concerns among scientists about how they’ve “encountered barriers that have hampered their research” into marijuana under federal prohibition, including “complex” federal regulations and inadequate supplies of cannabis.

That’s why the National Institutes of Health (NIH) is now seeking to resolve some of those challenges by standing up a Resource Center for Cannabis and Cannabinoid Research, an official said in a blog post on Tuesday.

NIH posted a notice of funding opportunity late last month, explaining how it’s seeking an entity to operate the center through a cooperative agreement in order to “address challenges and barriers to conducting research on cannabis and its constituents.”

To help facilitate that process, the National Center for Complementary and Integrative Health’s (NCCIH) Patrick Still announced that the health agency will be holding a webinar on January 25 to provide potential applicants with technical assistance.

“There’s growing interest in potential therapeutic uses of cannabis and its constituents among both health care providers and the public,” Still, who is a program director for NCCIH’s Basic and Mechanistic Research branch, wrote. “Substances in cannabis have a variety of pharmacologic effects, and rigorous research is needed to understand their mechanisms of action and investigate their possible value in helping to manage health conditions.”

“However, investigators working in this field have encountered barriers that have hampered their research,” he said, pointing to feedback NCCIH received as part of a request for information last year.

“The barriers that many of them have mentioned include difficulty meeting complex federal and state regulatory requirements, problems obtaining cannabis products suitable for research, a lack of validated measures of cannabis use and exposure, and inadequate scientific infrastructure to support research studies,” Still wrote.

Keep reading